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Many cases of acne vulgaris do not respond
sufficiently well to topical or systemic treat-
ment and it is frequently necessary to resort to
x-ray therapy. (Andrews et at. (1), Belisario (3),
Crawford et at. (5), Monash (12), Robinson (13),
and Sulzberger, Baer and Borota (18).) Most
eases are improved by x-rays, but safe dosage
limits this treatment to a single course. Since re-
lapses are not uncommon, this constitutes a
serious disadvantage.
Grenz, or Bucky rays have a larger margin of
safety which permits repeated courses of treat-
ment in the event of relapse. About 75 per cent
of the radiation is absorbed in the first 0.5 mm. of
skin and 90 per cent in the first 1.0 mm (Ebbehøj
(6, 7), Hollander (8)). The penetration of grenz
rays being so superficial, some authorities have
suggested that they are not very effective in
treating acne (Sulzberger and Baer (17), Baer and
Witten (2)), although others have reported them
to be of vaiue (Bueky and Combes (4), Kaalund
JØrgensen (9), Kalz (10), Lomholt (11), Ryan
(14), Sagher (15)).
This report presents a series of eases of acne
vulgaris treated by grenz rays with a significant
incidence of good results, and which were fol-
lowed up for periods of up to 15 years.
CASE MATERIAL
The 139 patients included in this study were
from 14 to 34 years of age. Eighty nine were fe-
males, 50 males. All had already been unsuccess-
fully treated by such means as shake lotions con-
taining sulfur, resoreinol or mercury; compresses;
carbon dioxide-acetone-sulfur-slush; sex hor-
mones; vitamin A; autovaeeines; sulfonamides;
and antibiotics. These external remedies were
discontinued during treatment and usually only
the application of face powder was allowed.
The acne had been present for one to twelve
years before grenz ray treatment was started.
Thirty four eases were of the severe indurated,
cystic type, the rest of the uncomplicated type.
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Patients who had been previously treated with
x-rays were not accepted for treatment with
grenz-rays.
METHOD OF TREATMENT
The rays were administered at 10-12 KY, cor-
responding to a half value layer of 0.025—0.028
mm aluminum. In most eases, rays at 10 KY
were used. For the cheeks and back the target-
skin distance was 15 cm and for parts such as the
forehead and the pcrioral region, 10 cm. The
eyelids and lips were covered with either lead
shields or 25 per cent bismuth paste.
One hundred patients were treated by an in-
tensive schedule using the technic of Samek (16)
and Kalz (10). Doses of 100 r were given, at first
every 1 to 2 days until 600—700 r had been ad-
ministered, and subsequently at intervals of 3
to 7 days.
The remaining 39 patients were treated once
weekly with doses of from 200 to 300 r.
The total dose for a single course in either treat-
ment schedule varied from 600 to 2,300 r. Twenty
six patients received from 600 to 1,000 r, 72 from
1,000 to 1,500 r, and 41 from 1,500 to 2,300 r.
The higher doses in the region of 2,000 r were
mostly reserved for patients with indurated
cystic forms of the disease.
The lower doses were given in less severe eases
and the treatments were stopped when the clini-
cal effect became satisfactory.
Some patients whose condition relapsed,
usually after about a year, were re-treated. Eight
received two courses, and three were given three
courses. The dose in the subsequent courses was
about the same as in the first, so that the total
dose for those receiving 2 courses was 2,000—
2,500 r, and for those receiving three courses
about 3,500—4,000 r.
Biological and Clinical Effects of Irradiations
The erythema producing effect of the irradia-
tion differed according to the treatment schedule.
In white patients of average pigmentation who
received the intensive treatment a slight
erythema appeared after 500—700 r had been ad-
ministered and became much more marked be-
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tween 700 r and 1,000 r. For this reason, irradia-
tions were given only once or twice weekly after
700 r had been received.
The crythema was not accompanied by pain
but by a prickly sensation comparable to that of
sunburn. During this period new elements and
pustules sometimes occurred, but such pustules
dried up very quickly. After about 1,000 r had
been administered the skin became very dry,
especially around the mouth and over the zygo-
matic area. Since these areas are usually free of
acne lesions they were covered by a lead shield
for subsequent irradiations.
In most cases the erythema disappeared during
the final weekly irradiations, about a month after
beginning of treatment. The dryness of the skin
continued for several months and only in a few
patients did facies oleosa recur after a lapse of
one year or more. The area around the nose and
naso-labial folds very rarely became dry.
During the height of the erythema the skin
had a bluish-red color. The degree of peeling
which followed the erythema varied in different
patients and was more marked in those of fair
complexion. A brownish pigmentation appeared
about 2 months after the start of treatment and
persisted for several more months. Patchy pig-
mentation mainly occurred in fair people. In
rare eases this patchy pigmentation remained
for up to one year and was very unpleasant.
Therefore the treatment schedule in these pa-
tients should be less intense.
During the non-intensive treatment schedule
erythema did not appear at all, or was of very
minor degree and mainly in patients giving a
history of exposure to the sun during the course
of treatment.
Since a combination of grenz rays and strong
sunlight is undesirable all patients were advised
against exposure to the sun both during the period
of treatment and for a month afterwards. Pa-
tients not following this rule developed a marked
erythema and swelling of the face.
In cystic acne a beneficial influence was ob-
served in all the acne lesions except the cysts.
RESULTS
Influence of Total Dosage
The best results were obtained with total doses
of over 1,500 r. In the group of 41 patients re-
ceiving this dosage 71 per cent were markedly
improved, with complete or almost complete dis-
appearance of the lesions. There was slight im-
provement in 24 per cent and no improvement in
5 per cent. In the two groups receiving lower total
dosage the proportion of good results was smaller,
there being little difference between those getting
less than 1,000 r and those receiving 1,000 r to
1,500 r (Table I).
TABLE I
Results in 139 acne patients according to the total dose
Total Dose Number of d
15
41
29
Per Cent
58
57
71
Imeovd
8
25
10
Per Cent
31
35
24
Improved
3
6
2
Per Cent
11
8
5
Less than 1,000 r
1,000rtol,500r
Over 1,500 r
26
72
41
Total 139 85 61 43 31 11 8
TABLE II
Results of grenz ray therapy in 139 patients according to rarious dosage schedules
Treatment Schedole Per Cent 'd Per Cent Imed Per Cent
Intensive
Weekly
100
39
71
14
71
36
20
23
20
59
9
2
9
5
Total 139 85 61 43 31 11 8
GRENZ RAY TREATMRNT OF ACNR VULGARIS 105
Influence of Treatment Schedules
Of 100 patients receiving the intensive treat-
ment schedule, 71 were markedly improved, 20
were slightly improved and 9 were not improved.
When weekly doses of 200 to 300 r were applied
in a group of 39 cases, only 36 per cent were
markedly improved, 59 per cent slightly im-
proved, and 5 per cent were not improved (Table
II).
Sequelae
All the patients were requested to report for
follow-up examinations. Seventy three were ob-
served for periods of up to 15 years. No late
sequelae such as telangiectasiae or atrophy,
were observed even in those patients who re-
ceived 2 or 3 courses of grenz ray treatment.
DISCUSSION
The results obtained in this series seem to be
in contrast with the less satisfactory results of
Sulzberger and Baer (17), Baer and Witten (2),
and ascribed by them to the low penetrating
power of grenz rays. Sulzberger (17) has sug-
gested that only a slight peeling, with consequent
unplugging of the follicle openings, is produced
by the superficial action of these rays, and that
there is comparatively little inhibition of se-
baceous gland activity. However, in most of the
patients who received the intensive treatment
schedule there was a well developed erythema,
conspicuous peeling and marked dryness of the
skin. The dryness sometimes persisted for many
months. Sulzberger and Baer (17) used doses of
200 r repeated only four times at intervals of
four to seven days. Our best results were obtained
with irradiation every one or two days, and total
doses of over 1,500 r. These differences in fre-
quency of treatment and total dosage appear
to be the main reasons for the disparity in the
results.
In our opinion grenz rays are as effective as
x-rays in the treatment of acne. Adequate therapy
takes a total of only 4 to 6 weeks, although the
frequency of the treatments might inconvenience
some patients. If relapse occurred after an in-
terval of not less than one year further treat-
ments were given, up to a maximum of three
courses.
To exclude the possibility of a spontaneous re-
mission occurring during the course of treat-
ment, either the face or the back of ten patients
who had lesions in both these areas was not
treated. Improvement occurred in the treated
but not in the untreated area. Moreover, in some
cases, during and following irradiation, new
lesions developed in areas outside the irradiated
fields, such as under the chin.
The disadvantages of the grcnz ray treatment
are temporary crythema, scaling and the frequent
dryness and itching of the skin. Sometimes,
particularly in those with fair complexions,
patchy pigmentation lasting weeks or months
may occur (Baer and Witten (2)). Furthermore,
the dose at each treatment must be timed in
seconds, which necessitates very careful super-
vision.
SUMMARY
One hundred and thirty nine patients with acne
vulgaris were treated ivith grenz rays after not
responding to other external and to systemic
therapy.
Of 100 patients who received an intensive
treatment schedule, 71 were markedly improved.
Of the 39 who received a more prolonged course
of treatment, only 14 were similarly improved.
The highest percentage of marked improve-
ment occurred in those patients who had received
a total dose of over 1,500 r. No significant ill-
effect of the radiation was observed during fol-
low-up periods of up to 15 years.
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